[go: up one dir, main page]

IL91304A0 - Recombinant vaccinia virus for prevention of disease caused by flavivirus - Google Patents

Recombinant vaccinia virus for prevention of disease caused by flavivirus

Info

Publication number
IL91304A0
IL91304A0 IL91304A IL9130489A IL91304A0 IL 91304 A0 IL91304 A0 IL 91304A0 IL 91304 A IL91304 A IL 91304A IL 9130489 A IL9130489 A IL 9130489A IL 91304 A0 IL91304 A0 IL 91304A0
Authority
IL
Israel
Prior art keywords
flavivirus
prevention
vaccinia virus
disease caused
recombinant vaccinia
Prior art date
Application number
IL91304A
Original Assignee
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Health filed Critical Us Health
Publication of IL91304A0 publication Critical patent/IL91304A0/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011Details
    • C12N2710/24011Poxviridae
    • C12N2710/24111Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL91304A 1988-08-20 1989-08-14 Recombinant vaccinia virus for prevention of disease caused by flavivirus IL91304A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23920588A 1988-08-20 1988-08-20

Publications (1)

Publication Number Publication Date
IL91304A0 true IL91304A0 (en) 1990-03-19

Family

ID=22901085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL91304A IL91304A0 (en) 1988-08-20 1989-08-14 Recombinant vaccinia virus for prevention of disease caused by flavivirus

Country Status (5)

Country Link
EP (1) EP0431064A4 (en)
JP (1) JPH03503364A (en)
AU (1) AU624863B2 (en)
IL (1) IL91304A0 (en)
WO (1) WO1990001946A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US6676936B1 (en) 1988-07-14 2004-01-13 The United States Of America As Represented By The Department Of Health And Human Services. Chimeric and/or growth-restricted flaviviruses
US6184024B1 (en) 1988-07-14 2001-02-06 The United States Of America As Represented By The Department Of Health And Human Services Chimeric and/or growth-restricted flaviviruses
CA2018332A1 (en) * 1989-06-06 1990-12-06 Franz X. Heinz Proteins, vaccines and nucleic acids
MY109299A (en) * 1990-08-15 1996-12-31 Virogenetics Corp Recombinant pox virus encoding flaviviral structural proteins
EP1605047B1 (en) * 1991-09-19 2009-09-16 The United States of America, as represented by the Secretary Department of Health and Human Services Chimeric and/or growth-restricted flaviviruses
US6117640A (en) * 1995-05-02 2000-09-12 The United States Of America As Represented By The Secretary Of The Army Recombinant vaccine made in E. coli against dengue virus
CA2224724C (en) * 1995-05-24 2007-12-04 Hawaii Biotechnology Group, Inc. Subunit vaccine against flavivirus infection
AU4556597A (en) 1996-09-24 1998-04-17 Bavarian Nordic Research Institute A/S Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines
ATE468858T1 (en) * 1997-02-28 2010-06-15 Acambis Inc CHIMERIC VACCINES AGAINST FLAVIVIRUS
WO1999063095A1 (en) 1998-06-04 1999-12-09 The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Nucleic acid vaccines for prevention of flavivirus infection
US7227011B2 (en) 1998-06-04 2007-06-05 United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention Nucleic acid vaccines for prevention of flavivirus infection
CA2941182A1 (en) 2000-02-16 2001-08-23 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Avirulent, immunogenic flavivirus chimeras
WO2003048184A2 (en) * 2001-12-04 2003-06-12 Bavarian Nordic A/S Flavivirus ns1 subunit vaccine
CA2432738A1 (en) 2003-02-26 2004-08-26 Philippe Despres New dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications
MX374519B (en) 2013-03-15 2025-03-06 Us Gov Health & Human Services COMPOSITIONS AND METHODS OF CHIMERICAL CONSTRUCTIONS OF THE DENGUE VIRUS IN VACCINES.
US11464815B2 (en) 2018-09-05 2022-10-11 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
US11426461B2 (en) 2018-09-05 2022-08-30 Takeda Vaccines, Inc. Methods for preventing dengue and hepatitis A
CA3111332A1 (en) 2018-09-05 2020-03-12 Takeda Vaccines, Inc. Dengue vaccine unit dose and administration thereof
US12280099B2 (en) 2019-03-14 2025-04-22 Tokyo Metropolitan Institute Of Medical Science Dengue virus vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH084508B2 (en) * 1987-09-16 1996-01-24 国立予防衛生研究所長 Recombinant vaccinia virus

Also Published As

Publication number Publication date
AU624863B2 (en) 1992-06-25
AU4206489A (en) 1990-03-23
WO1990001946A1 (en) 1990-03-08
EP0431064A4 (en) 1991-11-13
JPH03503364A (en) 1991-08-01
EP0431064A1 (en) 1991-06-12

Similar Documents

Publication Publication Date Title
IL91304A0 (en) Recombinant vaccinia virus for prevention of disease caused by flavivirus
GB2246784B (en) Herpes virus recombinant poxvirus vaccine
AR241939A1 (en) Recombinant avipox virus
GB8821528D0 (en) Recombinant vaccinia virus
ATA257190A (en) VIRAL POLYPEPTIDE
DK603888A (en) RECOMBINANT VIRUS
AU6028690A (en) Lhrh analogs
IT1239987B (en) SPECTRUM SELECTION SYSTEM OF INFECTIVITY OF RECOMBINANT POXVIRUS
NO892251L (en) PROCEDURE FOR THE PREPARATION OF COCOCOIDOSE VACCINE BY RECOMBINANT TECHNIQUES.
HU912526D0 (en) Recombinant marek-type disease virus
ZM9387A1 (en) Treatment of diseases caused by viruses
DK197989D0 (en) peptide analogs
IL93367A0 (en) Fine-grained microstructure processor
GB8916391D0 (en) Preparation of polyacetals
ITMI931371A0 (en) PROCEDURE FOR THE PREPARATION OF ERDOSTEINE
EP0428103A3 (en) Prevention of glycoprotein enveloped virus infectivity by pyridyloxazole-2-ones
GB8917059D0 (en) Avipox virus promoters
EP0417825A3 (en) Cymenol preparation by direct dehydrogenation
AU8132287A (en) Recombinant vaccinia virus
GB8914680D0 (en) Prevention of aid virus
ZA886415B (en) Recombinant avipox virus
IL84541A0 (en) Pharmaceutical composition for treating a disease caused by virus
IE870898L (en) Recombinant vaccinia virus.
IE892593L (en) Treatment of virus diseases
PL274522A1 (en) Surgical mask